These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 29845226

  • 1. Downregulation of microRNA‑449a‑5p promotes esophageal squamous cell carcinoma cell proliferation via cyclin D1 regulation.
    Jiang T, Liu J, Mu J.
    Mol Med Rep; 2018 Jul; 18(1):848-854. PubMed ID: 29845226
    [Abstract] [Full Text] [Related]

  • 2. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
    Jiang S, Zhao C, Yang X, Li X, Pan Q, Huang H, Wen X, Shan H, Li Q, Du Y, Zhao Y.
    Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
    [Abstract] [Full Text] [Related]

  • 3. miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis.
    Zhang W, Lei C, Fan J, Wang J.
    Biochem Biophys Res Commun; 2016 Aug 12; 477(1):144-149. PubMed ID: 27291152
    [Abstract] [Full Text] [Related]

  • 4. Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1.
    Jiang L, Zhao Z, Zheng L, Xue L, Zhan Q, Song Y.
    Genomics Proteomics Bioinformatics; 2017 Jun 12; 15(3):208-217. PubMed ID: 28602785
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q, Zhang HY, Zhong BL, Wang XJ, Zhang B, Chen H.
    Med Sci Monit; 2016 Oct 23; 22():3925-3934. PubMed ID: 27771733
    [Abstract] [Full Text] [Related]

  • 6. MiR-214 inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by targeting CDC25B.
    Wang M, Wang L, Zhang M, Li X, Zhu Z, Wang H.
    Biomed Pharmacother; 2017 Nov 23; 95():1678-1683. PubMed ID: 28954387
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y, Yi J, Zhang K, Bai F, Feng B, Wang R, Chu X, Chen L, Song H.
    J Exp Clin Cancer Res; 2017 Nov 16; 36(1):161. PubMed ID: 29145896
    [Abstract] [Full Text] [Related]

  • 8. miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells.
    Lin C, Huang F, Li QZ, Zhang YJ.
    Int J Clin Exp Pathol; 2014 Nov 16; 7(10):6543-50. PubMed ID: 25400732
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
    Gao X, Xie Z, Wang Z, Cheng K, Liang K, Song Z.
    Yonsei Med J; 2017 Nov 16; 58(6):1101-1110. PubMed ID: 29047233
    [Abstract] [Full Text] [Related]

  • 10. [FAT1 inhibits cell proliferation of esophageal squamous cell carcinoma through regulating the expression of CDK4/CDK6/CCND1 complex].
    Hu XL, Zhai YF, Li GD, Xing JF, Yang J, Bi YH, Wang J, Shi RY.
    Zhonghua Zhong Liu Za Zhi; 2018 Jan 23; 40(1):14-20. PubMed ID: 29365412
    [Abstract] [Full Text] [Related]

  • 11. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
    Zhu ZQ, Hu HF, Zheng XY, Wang F.
    Zhonghua Zhong Liu Za Zhi; 2020 Aug 23; 42(8):635-643. PubMed ID: 32867454
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma.
    Yang B, Xie R, Wu SN, Gao CC, Yang XZ, Zhou JF.
    Oncol Rep; 2018 Jan 23; 39(1):255-263. PubMed ID: 29115555
    [Abstract] [Full Text] [Related]

  • 13. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
    Wang F, Wang J, Yang X, Chen D, Wang L.
    Diagn Pathol; 2016 Sep 15; 11(1):88. PubMed ID: 27628042
    [Abstract] [Full Text] [Related]

  • 14. [Expression of microRNA-17-5p in esophageal squamous cell carcinoma and its effects on cell proliferation and invasion].
    Xu H, Meng XR, Zhou Y, Wang F.
    Zhonghua Zhong Liu Za Zhi; 2020 Feb 23; 42(2):105-113. PubMed ID: 32135643
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
    Li M, He XY, Zhang ZM, Li S, Ren LH, Cao RS, Feng YD, Ji YL, Zhao Y, Shi RH.
    World J Gastroenterol; 2015 Mar 21; 21(11):3245-55. PubMed ID: 25805931
    [Abstract] [Full Text] [Related]

  • 16. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells.
    Li X, Chen D, Li M, Gao X, Shi G, Zhao H.
    Chem Biol Interact; 2018 May 25; 288():76-82. PubMed ID: 29680210
    [Abstract] [Full Text] [Related]

  • 17. Targeting of miR-150 on Gli1 gene to inhibit proliferation and cell cycle of esophageal carcinoma EC9706.
    Sun J, Wang D, Li X, Yan J, Yuan X, Wang W.
    Cancer Biomark; 2017 Dec 12; 21(1):203-210. PubMed ID: 29081413
    [Abstract] [Full Text] [Related]

  • 18. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T, Cao R, Li S, Fu M, Ren L, Chen W, Zhu H, Zhan Q, Shi R.
    BMC Cancer; 2015 Jan 31; 15():29. PubMed ID: 25637514
    [Abstract] [Full Text] [Related]

  • 19. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
    Islam F, Gopalan V, Law S, Tang JC, Chan KW, Lam AK.
    Hum Pathol; 2017 Apr 31; 62():141-151. PubMed ID: 28188753
    [Abstract] [Full Text] [Related]

  • 20. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
    Liu C, Tian X, Sun HB, Wang ZF, Jiang LF, Li ZX.
    Eur Rev Med Pharmacol Sci; 2019 Feb 31; 23(3):1069-1076. PubMed ID: 30779074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.